Personalized testing of drugs for glioblastoma stem cells
Part of Brain & nervous system, Cancer clinical trials.
This early trial tries to find which medicines might work best for your specific glioblastoma, by testing drugs on cancer “stem cell” samples. If the test finds promising drug options, it may guide a more personalized treatment approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a confirmed diagnosis of glioblastoma (brain cancer, grade 4)
- Your doctors plan surgery to remove most or nearly all of the tumor that can be reached surgically
- Your health status is high enough (KPS score 70 or higher) and you have a life expectancy over 6 months
- You have not had any prior whole-body (systemic) cancer drug treatment
- Your blood and liver/kidney tests are within required safety ranges (for example, hemoglobin >8, neutrophils >1,000, platelets >100,000; kidney and liver numbers not too high)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether testing drugs on your tumor cells in a lab can help find the best treatment for you. It is for people with a specific type of glioblastoma that has not been treated yet.
This trial tests whether customized drug screening on your tumor cells can help doctors choose the best treatment for you. Your tumor cells will be grown in the lab and tested against different drugs to find what works best, combined with short-course radiation therapy.
This study tests a new way to choose treatment for people with brain tumors that have not responded to standard therapies. Your tumor sample is analyzed in the lab to find which drugs might work best for you, and then you receive a personalized treatment plan.
This trial tests whether using your own blood stem cells to support high-dose chemotherapy can help treat newly diagnosed glioblastoma, an aggressive brain cancer. It aims to improve outcomes for patients whose tumors have a specific genetic marker (unmethylated MGMT) and who have had surgery.
This trial tests a combination of several drugs and a vaccine to see if they can help treat glioma that has not gone away with previous treatment. It is for people whose tumors have certain gene changes and who still have some tumor remaining after standard therapy.
This trial tests a personalized cancer vaccine made from your own tumor, combined with standard chemotherapy and a drug that helps your immune system fight the cancer. It aims to see if this combination can improve outcomes for people with glioblastoma.
Hear when a new Newly Diagnosed Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.